The National Transportation Safety Board on Tuesday recommended states lower allowable blood-alcohol levels for drivers, from 0.08 percent to 0.05 percent.
Category results for "Government"
When Florida Attorney General Pam Bondi took office in 2011, Florida was in the midst of a public safety crisis of epic proportions – prescription drug abuse. This epidemic wasn’t just affecting adults. It was affecting increasing numbers of pregnant women throughout the state, which fueled an explosion in cases of neonatal abstinence syndrome, babies being born exposed to prescription drugs.
Parents should start talking with their children about the dangers of drinking as early as age 9, according to a new government campaign.
The Food and Drug Administration on Friday denied a request from the maker of the painkiller Opana ER to block generic forms of the drug. The decision came as a surprise, Reuters reports.
Commentary: National Prevention Week 2013 Is May 12-18: Participate and Make a Difference in Your Community!
The Substance Abuse and Mental Health Services Administration’s second annual National Prevention Week begins on Sunday, May 12. This national health observance, which continues through May 18, aims to increase public awareness of, and action around, substance abuse and mental health issues.
Florida is launching a new initiative to tackle the growing problem of newborns exposed to prescription drugs, The Miami Herald reports.
Legislators in Colorado on Wednesday passed the first laws regulating the state’s recreational marijuana market, which will take effect in January 2014. Governor John Hickenlooper is expected to sign them by early June, The Wall Street Journal reports.
More than a dozen drug companies are working on abuse-resistant painkillers, in the wake of the Food and Drug Administration’s decision last month not to approve any generic versions of the original form of OxyContin.
Fifty percent more pills were collected during the latest National Prescription Drug Take-Back Day, compared with the previous event in 2012, the Drug Enforcement Administration announced.
The Food and Drug Administration this week asked for more information on an implant designed to treat opioid addiction, before making a decision on whether to approve the drug, according to Bloomberg News.